BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30948480)

  • 1. Pituitary gigantism: a rare learning opportunity.
    Bendor-Samuel OM; Pal A; Cudlip S; Anderson G; Salgia S; Makaya T
    Arch Dis Child Educ Pract Ed; 2020 Apr; 105(2):111-116. PubMed ID: 30948480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism--effect of octreotide therapy.
    Schoof E; Dörr HG; Kiess W; Lüdecke DK; Freitag E; Zindel V; Rascher W; Dötsch J
    Horm Res; 2004; 61(4):184-9. PubMed ID: 14739526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary gigantism: a case series from Hospital de San José (Bogotá, Colombia).
    García WR; Cortes HT; Romero AF
    Arch Endocrinol Metab; 2019 Jul; 63(4):385-393. PubMed ID: 31365626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pituitary gigantism.
    Lu PW; Silink M; Johnston I; Cowell CT; Jimenez M
    Arch Dis Child; 1992 Aug; 67(8):1039-41. PubMed ID: 1520009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The causes and consequences of pituitary gigantism.
    Beckers A; Petrossians P; Hanson J; Daly AF
    Nat Rev Endocrinol; 2018 Dec; 14(12):705-720. PubMed ID: 30361628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of pituitary gigantism.
    Cunha C; Saraiva C; Canas Marques C; Duarte JS
    BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34972788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary gigantism.
    Daughaday WH
    Endocrinol Metab Clin North Am; 1992 Sep; 21(3):633-47. PubMed ID: 1521516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous remission of acromegaly or gigantism due to subclinical apoplexy of pituitary growth hormone adenoma.
    Wang XL; Dou JT; Lü ZH; Zhong WW; Ba JM; Jin D; Lu JM; Pan CY; Mu YM
    Chin Med J (Engl); 2011 Nov; 124(22):3820-3. PubMed ID: 22340248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gigantism caused by growth hormone secreting pituitary adenoma.
    Rhee N; Jeong K; Yang EM; Kim CJ
    Ann Pediatr Endocrinol Metab; 2014 Jun; 19(2):96-9. PubMed ID: 25077093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pegvisomant treatment in gigantism caused by a growth hormone-secreting giant pituitary adenoma.
    Müssig K; Gallwitz B; Honegger J; Strasburger CJ; Bidlingmaier M; Machicao F; Bornemann A; Ranke MB; Häring HU; Petersenn S
    Exp Clin Endocrinol Diabetes; 2007 Mar; 115(3):198-202. PubMed ID: 17427111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous endocrine cure of gigantism due to pituitary apoplexy.
    Arisaka O; Hall R; Hughes IA
    Br Med J (Clin Res Ed); 1983 Oct; 287(6398):1007-8. PubMed ID: 6311318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of type 2 diabetes mellitus associated with pituitary gigantism.
    Ali O; Banerjee S; Kelly DF; Lee PD
    Pituitary; 2007; 10(4):359-64. PubMed ID: 17629784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pegvisomant therapy in pituitary gigantism: successful treatment in a 12-year-old girl.
    Rix M; Laurberg P; Hoejberg AS; Brock-Jacobsen B
    Eur J Endocrinol; 2005 Aug; 153(2):195-201. PubMed ID: 16061823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial X-Linked Acrogigantism: Postnatal Outcomes and Tumor Pathology in a Prenatally Diagnosed Infant and His Mother.
    Wise-Oringer BK; Zanazzi GJ; Gordon RJ; Wardlaw SL; William C; Anyane-Yeboa K; Chung WK; Kohn B; Wisoff JH; David R; Oberfield SE
    J Clin Endocrinol Metab; 2019 Oct; 104(10):4667-4675. PubMed ID: 31166600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eight-year follow-up of a child with a GH/prolactin-secreting adenoma: efficacy of pegvisomant therapy.
    Bergamaschi S; Ronchi CL; Giavoli C; Ferrante E; Verrua E; Ferrari DI; Lania A; Rusconi R; Spada A; Beck-Peccoz P
    Horm Res Paediatr; 2010; 73(1):74-9. PubMed ID: 20190543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pituitary gigantism causing diabetic ketoacidosis.
    Alvi NS; Kirk JM
    J Pediatr Endocrinol Metab; 1999; 12(6):907-9. PubMed ID: 10614552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary gigantism caused by growth hormone excess from infancy.
    Gelber SJ; Heffez DS; Donohoue PA
    J Pediatr; 1992 Jun; 120(6):931-4. PubMed ID: 1593354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Outcome of somatostatin analogue treatment in acromegaly].
    Mondok A; Tóth M; Patócs A; Szücs N; Igaz P; Pusztai P; Czirják S; Beko G; Gláz E; Rácz K; Tulassay Z
    Orv Hetil; 2009 Aug; 150(31):1457-62. PubMed ID: 19617182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation.
    Zimmerman D; Young WF; Ebersold MJ; Scheithauer BW; Kovacs K; Horvath E; Whitaker MD; Eberhardt NL; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1993 Jan; 76(1):216-22. PubMed ID: 8421089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acromegaly and gigantism.
    Hartog M
    Practitioner; 1980 Feb; 224(1340):149-51. PubMed ID: 7367366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.